Table of Contents Author Guidelines Submit a Manuscript
Journal of Diabetes Research
Volume 2016, Article ID 1342643, 5 pages
http://dx.doi.org/10.1155/2016/1342643
Research Article

Intercellular Adhesion Molecule and Endogenous NOS Inhibitor: Asymmetric Dimethylarginine in Pregnant Women with Gestational Diabetes Mellitus

Chair and Department of Obstetrics and Perinatology, Medical University of Lublin, Jaczewskiego 8, 20-954 Lublin, Poland

Received 23 October 2015; Revised 8 January 2016; Accepted 13 January 2016

Academic Editor: Ilaria Campesi

Copyright © 2016 Elżbieta Poniedziałek-Czajkowska et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. A. Buchanan and A. H. Xiang, “Gestational diabetes mellitus,” The Journal of Clinical Investigation, vol. 115, no. 3, pp. 485–491, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. A. A. Quyyumi, “Endothelial function in health and disease: new insights into the genesis of cardiovascular disease,” American Journal of Medicine, vol. 105, no. 1, pp. 32S–39S, 1998. View at Google Scholar · View at Scopus
  3. H. Cai and D. G. Harrison, “Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress,” Circulation Research, vol. 87, no. 10, pp. 840–844, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. S.-Y. Kim, H.-M. Ryu, J. H. Yang et al., “Maternal serum levels of VCAM-1, ICAM-1 and E-selectin in preeclampsia,” Journal of Korean Medical Science, vol. 19, no. 5, pp. 688–692, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Matsumoto, Y. Sera, H. Nakamura, Y. Ueki, and S. Miyake, “Serum concentrations of soluble adhesion molecules are related to degree of hyperglycemia and insulin resistance in patients with type 2 diabetes mellitus,” Diabetes Research and Clinical Practice, vol. 55, no. 2, pp. 131–138, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. A. Vincent, E. J. Barrett, J. R. Lindner, M. G. Clark, and S. Rattigan, “Inhibiting NOS blocks microvascular recruitment and blunts muscle glucose uptake in response to insulin,” The American Journal of Physiology—Endocrinology and Metabolism, vol. 285, no. 1, pp. E123–E129, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. J. T. Kielstein, B. Impraim, S. Simmel et al., “Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans,” Circulation, vol. 109, no. 2, pp. 172–177, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Y. Lin, A. Ito, T. Asagami et al., “Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase,” Circulation, vol. 106, no. 8, pp. 987–992, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. M. López-Alarcón, I. Montalvo-Velarde, V. S. Vital-Reyes, J. C. Hinojosa-Cruz, A. Leaños-Miranda, and A. Martínez-Basila, “Serial determinations of asymmetric dimethylarginine and homocysteine during pregnancy to predict pre-eclampsia: a longitudinal study,” BJOG: An International Journal of Obstetrics & Gynaecology, vol. 122, no. 12, pp. 1586–1592, 2015. View at Publisher · View at Google Scholar
  10. P. N. Alpoim, L. C. Godoi, L. G. Freitas, K. B. Gomes, and L. M. Dusse, “Assessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsia,” Nitric Oxide, vol. 33, pp. 81–82, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. WHO, “Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy,” WHO/NMH/MND 13.2, 2013. View at Google Scholar
  12. P. M. Catalano, L. Huston, S. B. Amini, and S. C. Kalhan, “Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus,” American Journal of Obstetrics and Gynecology, vol. 180, no. 4, pp. 903–916, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Ito, A. Ohshima, M. Inoue et al., “Weight reduction decreases soluble cellular adhesion molecules in obese women,” Clinical and Experimental Pharmacology and Physiology, vol. 29, no. 5-6, pp. 399–404, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. T. Hamaguchi and M. Namba, “Insulin therapy in diabetic patient with hypertension,” Nippon Rinsho, vol. 61, no. 7, pp. 1238–1244, 2003. View at Google Scholar · View at Scopus
  15. N. Takeuchi, T. Kawamura, A. Kanai et al., “The effect of cigarette smoking on soluble adhesion molecules in middle-aged patients with Type 2 diabetes mellitus,” Diabetic Medicine, vol. 19, no. 1, pp. 57–64, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. B. Meigs, F. B. Hu, N. Rifai, and J. E. Manson, “Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus,” The Journal of the American Medical Association, vol. 291, no. 16, pp. 1978–1986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Bo, S. Valpreda, G. Menato et al., “Should we consider gestational diabetes a vascular risk factor?” Atherosclerosis, vol. 194, no. 2, pp. e72–e79, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Abe, K. Matsubara, H. Ochi, M. Ito, K. Oka, and K. Kameda, “Elevated levels of adhesion molecules derived from leukocytes and endothelial cells in patients with pregnancy-induced hypertension,” Hypertension in Pregnancy, vol. 22, no. 1, pp. 31–43, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Kuboki, Z. Y. Jiang, N. Takahara et al., “Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: a specific vascular action of insulin,” Circulation, vol. 101, no. 6, pp. 676–681, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Montagnani and M. J. Quon, “Insulin action in vascular endothelium: potential mechanisms linking insulin resistance with hypertension,” Diabetes, Obesity and Metabolism, vol. 2, no. 5, pp. 285–292, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Matsuoka, S. Itoh, M. Kimoto et al., “Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension,” Hypertension, vol. 29, no. 1, pp. 242–247, 1997. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Akturk, A. Altinova, I. Mert et al., “Asymmetric dimethylarginine concentrations are elevated in women with gestational diabetes,” Endocrine, vol. 38, no. 1, pp. 134–141, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. B. Telejko, A. Zonenberg, M. Kuzmicki et al., “Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes,” Acta Diabetologica, vol. 46, no. 4, pp. 303–308, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Marcovecchio, B. Widmer, C. Turner, D. B. Dunger, and R. N. Dalton, “Asymmetric dimethylarginine in young people with Type 1 diabetes: a paradoxical association with HbA1c,” Diabetic Medicine, vol. 28, no. 6, pp. 685–691, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Anderssohn, E. Schwedhelm, N. Lüneburg, R. S. Vasan, and R. H. Böger, “Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus,” Diabetes and Vascular Disease Research, vol. 7, no. 2, pp. 105–118, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Leiper, J. Murray-Rust, N. McDonald, and P. Vallance, “S-nitrosylation of dimethylarginine dimethylaminohydrolase regulates enzyme activity: further interactions between nitric oxide synthase and dimethylarginine dimethylaminohydrolase,” Proceedings of the National Academy of Sciences of the United States of America, vol. 99, no. 21, pp. 13527–13532, 2002. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Murray-Rust, J. Leiper, M. McAlister et al., “Structural insights into the hydrolysis of cellular nitric oxide synthase inhibitors by dimethylarginine dimethylaminohydrolase,” Nature Structural Biology, vol. 8, no. 8, pp. 679–683, 2001. View at Google Scholar
  28. J. Takaya, Y. Tanabe, Y. Kuroyanagi, and K. Kaneko, “Asymmetric dimethylarginine is negatively correlated with hyperglycemia in children,” Endocrine Journal, vol. 62, no. 6, pp. 551–556, 2015. View at Publisher · View at Google Scholar
  29. B. Ellger, M. C. Richir, P. A. M. Van Leeuwen et al., “Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity,” Endocrinology, vol. 149, no. 6, pp. 3148–3157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. F. Cosentino, K. Hishikawa, Z. S. Katusic, and T. F. Lüscher, “High glucose increases nitric oxide synthase expression and superoxide anion generation in human aortic endothelial cells,” Circulation, vol. 96, no. 1, pp. 25–28, 1997. View at Publisher · View at Google Scholar · View at Scopus
  31. Z. Dai, H.-Q. Zhu, D.-J. Jiang, J.-L. Jiang, H.-W. Deng, and Y.-J. Li, “17β-Estradiol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level,” International Journal of Cardiology, vol. 96, no. 2, pp. 223–227, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. U. N. Das, G. Repossi, A. Dain, and A. R. Eynard, “L-arginine, NO and asymmetrical dimethylarginine in hypertension and type 2 diabetes,” Frontiers in Bioscience, vol. 16, no. 1, pp. 13–20, 2011. View at Publisher · View at Google Scholar · View at Scopus